Barclays lowered the firm’s price target on Helmerich & Payne to $24 from $36 and keeps an Equal Weight rating on the shares following the Q4 report. Amid flattish activity in U.S. land this year, Helmerich is focused on international expansion, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HP:
- Helmerich & Payne: Strategic Positioning Amidst Challenges with a Cautious Optimism
- Ex-Dividend Date Nearing for These 10 Stocks – Week of February 10, 2025
- Helmerich & Payne price target lowered to $35 from $41 at RBC Capital
- Helmerich & Payne Reports Stable Revenue Amid Acquisition
- Helmerich & Payne’s Strategic Moves and Challenges